ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,306,319,218 | -10.4% | 48,132,615 | +1.5% | 0.13% | -7.6% |
Q2 2023 | $1,457,994,028 | -14.5% | 47,429,861 | +0.2% | 0.14% | -21.3% |
Q1 2023 | $1,706,037,085 | -12.3% | 47,350,458 | -3.8% | 0.18% | -17.2% |
Q4 2022 | $1,946,203,263 | -3.5% | 49,246,032 | -1.9% | 0.22% | -19.6% |
Q3 2022 | $2,016,482,000 | -6.9% | 50,186,161 | -2.6% | 0.28% | -2.1% |
Q2 2022 | $2,166,876,000 | +3.9% | 51,543,171 | -3.7% | 0.28% | 0.0% |
Q1 2022 | $2,085,987,000 | -6.9% | 53,541,788 | -4.8% | 0.28% | +1.4% |
Q4 2021 | $2,240,794,000 | +8.2% | 56,230,690 | -1.9% | 0.28% | -0.7% |
Q3 2021 | $2,071,013,000 | -0.5% | 57,305,311 | +12.8% | 0.28% | +1.5% |
Q2 2021 | $2,082,049,000 | -0.8% | 50,794,041 | +5.6% | 0.28% | -10.7% |
Q1 2021 | $2,098,917,000 | +76.2% | 48,118,242 | +102.2% | 0.31% | +67.4% |
Q4 2020 | $1,191,094,000 | +202.3% | 23,798,081 | +154.1% | 0.18% | +142.1% |
Q3 2020 | $394,053,000 | +30.8% | 9,366,618 | +50.9% | 0.08% | +13.4% |
Q2 2020 | $301,261,000 | – | 6,205,186 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |